Abbvie (ABBV) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

AbbVie Inc. (ABBV) ensures sustainable income through global expansion and patent protection in oncology and immunology. This EV/EBITDA enterprise value multiple chart visualizes the market valuation, where the value 18.88 characterizes this level. Production robotization and AI-driven molecule discovery are accelerating development, while the effective replacement of legacy blockbusters with new drugs stabilizes the company's financial performance.

EV/EBITDA determines the business value, including net debt, relative to operating profit before depreciation and amortization. By analyzing the EV/EBITDA ratio of a company while accounting for its debt load, an investor assesses the real price of the asset without the influence of the tax regime. This metric indicates the payback period of the enterprise, excluding accounting distortions. For AbbVie Inc. (ABBV), this is critical during aggressive acquisitions aimed at protecting the market from biosimilars and patent expirations.